Literature DB >> 28286328

Two distinct classes of degenerative change are independently linked to clinical progression in mild cognitive impairment.

Jean-Philippe Coutu1, Emily R Lindemer2, Ender Konukoglu3, David H Salat4.   

Abstract

We previously demonstrated 2 statistically distinct factors of degeneration in Alzheimer's disease: one strongly related to white matter damage and age interpreted as "age- and vascular-related", and the other related to cortical atrophy thought to represent "neurodegenerative changes associated with Alzheimer's disease". Those factors are now replicated in a distinct cross-sectional data set of 364 participants from the Alzheimer's Disease Neuroimaging Initiative and their interpretation is improved using correlations with CSF biomarkers. Furthermore, we now show that changes in both factors over 2 years are independently associated with decline in Mini-Mental State Examination score in a longitudinal subset of 116 individuals with mild cognitive impairment. Progression in the "age- and vascular-related" factor was greater for individuals with 2 APOE ε4 alleles and linked to a greater attributable change in Mini-Mental State Examination than the "neurodegenerative" factor. These results suggest benefits of targeting white matter and vascular health to complement interventions focused on the neurodegenerative aspect of the disease, even in individuals with little discernable vascular comorbidity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; CSF biomarkers; Cognitive decline; Longitudinal cohort study; Mild cognitive impairment; Small-vessel disease; White matter

Mesh:

Year:  2017        PMID: 28286328      PMCID: PMC5519085          DOI: 10.1016/j.neurobiolaging.2017.02.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  48 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease.

Authors:  Joong-Seok Kim; Si-Ryung Han; Sung-Woo Chung; Beum-Saeng Kim; Kwang-Soo Lee; Yeong-In Kim; Dong-Won Yang; Kwang-Soo Kim; Jong-Won Kim
Journal:  J Neurol Sci       Date:  2003-01-15       Impact factor: 3.181

Review 3.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

4.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

Review 5.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Authors:  Alida A Gouw; Alexandra Seewann; Wiesje M van der Flier; Frederik Barkhof; Annemieke M Rozemuller; Philip Scheltens; Jeroen J G Geurts
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

6.  Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study.

Authors:  Edo Richard; Alida A Gouw; Philip Scheltens; Willem A van Gool
Journal:  Stroke       Date:  2010-01-07       Impact factor: 7.914

7.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

8.  Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.

Authors:  Alida A Gouw; Wiesje M van der Flier; Franz Fazekas; Elisabeth C W van Straaten; Leonardo Pantoni; Anna Poggesi; Domenico Inzitari; Timo Erkinjuntti; Lars O Wahlund; Gunhild Waldemar; Reinhold Schmidt; Philip Scheltens; Frederik Barkhof
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

9.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

Authors:  M P Laakso; K Partanen; P Riekkinen; M Lehtovirta; E L Helkala; M Hallikainen; T Hanninen; P Vainio; H Soininen
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.

Authors:  Prashanthi Vemuri; Timothy G Lesnick; Scott A Przybelski; David S Knopman; Greg M Preboske; Kejal Kantarci; Mekala R Raman; Mary M Machulda; Michelle M Mielke; Val J Lowe; Matthew L Senjem; Jeffrey L Gunter; Walter A Rocca; Rosebud O Roberts; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2015-01-15       Impact factor: 13.501

View more
  12 in total

1.  Factors influencing accuracy of cortical thickness in the diagnosis of Alzheimer's disease.

Authors:  Mahanand Belathur Suresh; Bruce Fischl; David H Salat
Journal:  Hum Brain Mapp       Date:  2017-12-21       Impact factor: 5.038

2.  Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment.

Authors:  Chan-Mi Kim; Rachel L Alvarado; Kimberly Stephens; Hsiao-Ying Wey; Dany J J Wang; Elizabeth C Leritz; David H Salat
Journal:  Neurobiol Aging       Date:  2019-11-06       Impact factor: 4.673

3.  Regional age-related atrophy after screening for preclinical alzheimer disease.

Authors:  Lauren N Koenig; Pamela LaMontagne; Matthew F Glasser; Randall Bateman; David Holtzman; Igor Yakushev; Jasmeer Chhatwal; Gregory S Day; Clifford Jack; Catherine Mummery; Richard J Perrin; Brian A Gordon; John C Morris; Joshua S Shimony; Tammie L S Benzinger
Journal:  Neurobiol Aging       Date:  2021-09-15       Impact factor: 4.673

4.  Clinical outcomes in older surgical patients with mild cognitive impairment.

Authors:  Annie M Racine; Tamara G Fong; Yun Gou; Thomas G Travison; Douglas Tommet; Kristen Erickson; Richard N Jones; Bradford C Dickerson; Eran Metzger; Edward R Marcantonio; Eva M Schmitt; Sharon K Inouye
Journal:  Alzheimers Dement       Date:  2017-11-27       Impact factor: 21.566

5.  Heterogeneity of Cerebral White Matter Lesions and Clinical Correlates in Older Adults.

Authors:  Keun-Hwa Jung; Kimberly A Stephens; Kathryn M Yochim; Joost M Riphagen; Chan Mi Kim; Randy L Buckner; David H Salat
Journal:  Stroke       Date:  2021-01-07       Impact factor: 10.170

6.  Changes in Blood Factors and Ultrasound Findings in Mild Cognitive Impairment and Dementia.

Authors:  Kyoungjoo Cho; Jihye Kim; Gyung W Kim
Journal:  Front Aging Neurosci       Date:  2017-12-21       Impact factor: 5.750

7.  Advances in Studying Brain Morphology: The Benefits of Open-Access Data.

Authors:  Christopher R Madan
Journal:  Front Hum Neurosci       Date:  2017-08-04       Impact factor: 3.169

Review 8.  Comorbidity and progression of late onset Alzheimer's disease: A systematic review.

Authors:  Miriam L Haaksma; Lara R Vilela; Alessandra Marengoni; Amaia Calderón-Larrañaga; Jeannie-Marie S Leoutsakos; Marcel G M Olde Rikkert; René J F Melis
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

9.  The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment.

Authors:  Annie M Racine; Michael Brickhouse; David A Wolk; Bradford C Dickerson
Journal:  Alzheimers Dement (Amst)       Date:  2018-03-17

10.  The effect of white matter signal abnormalities on default mode network connectivity in mild cognitive impairment.

Authors:  Zhuonan Wang; Victoria J Williams; Kimberly A Stephens; Chan-Mi Kim; Lijun Bai; Ming Zhang; David H Salat
Journal:  Hum Brain Mapp       Date:  2019-11-19       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.